Accendra Health shareholders approve amended 2023 omnibus incentive plan at annual meeting

Accendra Health Inc

Accendra Health Inc

ACH

0.00
  • Accendra Health held its annual shareholder meeting on May 14, 2026.
  • Shareholders backed a slate of six director nominees for one-year terms.
  • KPMG LLP was ratified as independent registered public accounting firm for fiscal 2026.
  • Shareholders adopted amended and restated 2023 Omnibus Incentive Plan, authorizing board committee to make equity and incentive grants under plan terms; grants would be made through individual award agreements.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accendra Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-061888), on May 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.